EUVIMEDEUVIMED entdecken
Crossref

Tau Protein Elevation During a Single Hemodialysis Session in End-Stage Renal Disease Patients and Its Associations with Cardiovascular and Inflammatory Biomarkers

Agnieszka Bociek, Sylwia Terpiłowska, Kamila Bołtuć-Dziugieł, Joanna Roskal-Wałek, Jerzy Mosiewicz, Wojciech Dąbrowski, Andrzej Jaroszyński

Indian Journal of Nephrology · 04.08.2026 · 1-6

DOI: 10.25259/ijn_87_2026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Nephrology, online erschienen am 04.08.2026. Verfasst von Agnieszka Bociek und 6 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hemodialysis (HD) may be associated with cerebral hypoperfusion and neuronal stress in patients with end-stage renal disease (ESRD). This exploratory study assessed changes in serum concentrations of neuronal injury biomarkers, including Tau protein (Tau), during a single HD session and examined their associations with selected cardiovascular and inflammatory biomarkers. Materials and Methods Forty-four patients with ESRD undergoing maintenance HD were analyzed. Blood samples were collected immediately before and after one HD session to assess serum concentrations of selected biomarkers. Correlation and exploratory regression analyses were used to identify variables associated with change in Tau concentration (ΔTau) and post-HD ΔTau.

Results

Serum ΔTau increased after HD (394.36 ± 161.13 vs 469.78 ± 155.45 pg/mL, p = 0.0042), whereas GFAP, MBP, and S100B did not change significantly. Exploratory regression suggested that ΔTau was associated with ΔET-1, pre-HD parathormone, and pre-HD oxidized LDL (oxLDL). Post-HD Tau was mainly associated with post-HD ET-1, pre-HD ferritin, and QTc change; an alternative model including post-HD IL-6 instead of ferritin was also considered.

Conclusion

A single HD session was associated with increased serum ΔTau in patients with ESRD. The observed associations with ET-1, oxLDL, inflammatory markers, and QTc changes should be interpreted as exploratory and require validation in larger, independent cohorts.

Zitieren

APA

Bociek, A., Terpiłowska, S., Bołtuć-Dziugieł, K., Roskal-Wałek, J., Mosiewicz, J., Dąbrowski, W., & Jaroszyński, A. (2026). Tau Protein Elevation During a Single Hemodialysis Session in End-Stage Renal Disease Patients and Its Associations with Cardiovascular and Inflammatory Biomarkers. Indian Journal of Nephrology, 0, 1-6. https://doi.org/10.25259/ijn_87_2026

Vancouver

Bociek A, Terpiłowska S, Bołtuć-Dziugieł K, Roskal-Wałek J, Mosiewicz J, Dąbrowski W, et al. Tau Protein Elevation During a Single Hemodialysis Session in End-Stage Renal Disease Patients and Its Associations with Cardiovascular and Inflammatory Biomarkers. Indian Journal of Nephrology. 2026;0:1-6. doi:10.25259/ijn_87_2026

BibTeX
@article{Bociek2026,
  author = {Bociek, Agnieszka and Terpiłowska, Sylwia and Bołtuć-Dziugieł, Kamila and Roskal-Wałek, Joanna and Mosiewicz, Jerzy and Dąbrowski, Wojciech and Jaroszyński, Andrzej},
  title = {Tau Protein Elevation During a Single Hemodialysis Session in End-Stage Renal Disease Patients and Its Associations with Cardiovascular and Inflammatory Biomarkers},
  journal = {Indian Journal of Nephrology},
  year = {2026},
  volume = {0},
  pages = {1--6},
  doi = {10.25259/ijn_87_2026}
}
Kostenlos starten →